Conan G Kinsey (Conan Kinsey)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Artificial Intelligence

Top Venues

The Journal of experimental medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. eLife 13 (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. eLife 13 (2024)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Aria Vaishnavi, Joseph Juan, Maebh Jacob, Christopher M Stehn, Eric E Gardner, Michael T Scherzer, Sophia Schuman, J Edward Van Veen, Brandon Murphy, Christopher S Hackett, Adam J Dupuy, Stephen A Chmura, Louise van der Weyden, Justin Y Newberg, Annie Liu, Karen M Mann, Alistair G Rust, William A Weiss, Conan G Kinsey, David J Adams, Allie H Grossmann, Michael B Mann, Martin McMahon
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer research 82 (22) (2022)